All Stories

  1. Elemental imaging using laser-induced breakdown spectroscopy: A new and promising approach for biological and medical applications

    Article • Coordination Chemistry Reviews, March 2018, Elsevier

    Dr Lucie Sancey

  2. Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopy

    Article • Modern Pathology, November 2017, Nature

    Dr Lucie Sancey

  3. How should we plan the future of nanomedicine for cancer diagnosis and therapy?

    Article • International Journal of Pharmaceutics, November 2017, Elsevier

    Dr Lucie Sancey

  4. Laser spectroscopy for in situ elemental imaging of lung tissue: a promising technology

    Article • September 2017, European Respiratory Society (ERS)

    Dr Lucie Sancey

  5. Orotracheal manganese-enhanced MRI (MEMRI): An effective approach for lung tumor detection

    Article • NMR in Biomedicine, August 2017, Wiley

    Dr Lucie Sancey, Yannick Crémillieux

  6. Plasmon-mediated cancer phototherapy: the combined effect of thermal and photodynamic processes

    Article • Nanoscale, January 2017, Royal Society of Chemistry

    Dr Lucie Sancey

  7. Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Dr Lucie Sancey, Dr Julien Lupo

  8. Monte Carlo simulations guided by imaging to predict the in vitro ranking of radiosensitizing nanoparticles

    Article • International Journal of Nanomedicine, November 2016, Dove Medical Press

    Dr Lucie Sancey

  9. Safety Evaluation and Imaging Properties of Gadolinium-Based Nanoparticles in nonhuman primates

    Article • Scientific Reports, October 2016, Nature

    Dr Lucie Sancey

  10. MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection

    Article • Nanomedicine, September 2016, Future Medicine

    Dr Lucie Sancey

  11. Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy

    Article • Journal of Controlled Release, September 2016, Elsevier

    Dr Lucie Sancey

  12. The High Radiosensitizing Efficiency of a Trace of Gadolinium-Based Nanoparticles in Tumors

    Article • Scientific Reports, July 2016, Nature

    Dr Lucie Sancey

  13. WE-FG-BRA-07: Theranostic Nanoparticles Improve Clinical MR-Guided Radiation Therapy

    Article • Medical Physics, June 2016, Wiley

    Dr Lucie Sancey

  14. MO-FG-BRC-01: MR-Guided Radiation Therapy with Gadolinium Nanoparticles: From Chalkboard to First Clinical Trials

    Article • Medical Physics, June 2016, Wiley

    Dr Lucie Sancey

  15. An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors

    Article • Scientific Reports, February 2016, Nature

    Dr Lucie Sancey

  16. MRI T1 WEIGHTED THERANOSTIC NANODEVICES

    Article • February 2016, World Scientific Pub Co Pte Lt

    Dr Lucie Sancey

  17. Nanoparticle Enhanced MRI-Guided Radiation Therapy: Final proof of concept before phase I trial.

    Article • Radiotherapy and Oncology, February 2016, Elsevier

    Dr Lucie Sancey

  18. Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy

    Article • Nano Letters, October 2015, American Chemical Society (ACS)

    Dr Lucie Sancey

  19. Nanoparticules ultrafines en radiothérapie : le cas des AGuIX

    Article • Cancer/Radiothérapie, October 2015, Elsevier

    Dr Lucie Sancey

  20. Ultrasmall Nanoplatforms as Calcium-Responsive Contrast Agents for Magnetic Resonance Imaging

    Article • Small, July 2015, Wiley

    Dr Lucie Sancey

  21. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization

    Article • Nanomedicine, June 2015, Future Medicine

    Dr Lucie Sancey

  22. Gadolinium nanoparticles and contrast agent as radiation sensitizers

    Article • Physics in Medicine and Biology, May 2015, Institute of Physics Publishing

    Dr Lucie Sancey

  23. Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment

    Article • Cancer Nanotechnology, July 2014, Springer Science + Business Media

    Dr Lucie Sancey

  24. Laser-induced Breakdown Spectroscopy: A New Approach for Nanoparticle's Mapping and Quantification in Organ Tissue

    Article • Journal of Visualized Experiments, June 2014, MyJove Corporation

    Dr Lucie Sancey

  25. MnII-containing coordination nanoparticles as highly efficient T1 contrast agents for magnetic resonance imaging

    Article • Chemical Communications, January 2014, Royal Society of Chemistry

    Dr Lucie Sancey

  26. Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detection

    Article • EJNMMI Physics, January 2014, Springer Science + Business Media

    Dr Lucie Sancey

  27. Effect of particle size on the biodistribution of lipid nanocapsules: Comparison between nuclear and fluorescence imaging and counting

    Article • International Journal of Pharmaceutics, September 2013, Elsevier

    Dr Lucie Sancey

  28. In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles

    Article • Chemical Communications, January 2013, Royal Society of Chemistry

    Dr Lucie Sancey

  29. Development of gadolinium based nanoparticles having an affinity towards melanin

    Article • Nanoscale, January 2013, Royal Society of Chemistry

    Dr Lucie Sancey

  30. Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution

    Article • Advanced Drug Delivery Reviews, February 2012, Elsevier

    Dr Lucie Sancey

  31. The multiple roles of amphiregulin in human cancer

    Article • Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, December 2011, Elsevier

    Dr Lucie Sancey

  32. Targeted delivery of a proapoptotic peptide to tumorsin vivo

    Article • Journal of Drug Targeting, December 2010, Taylor & Francis

    Dr Lucie Sancey

  33. Optical small animal imaging in the drug discovery process

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, December 2010, Elsevier

    Dr Lucie Sancey

  34. Amphiregulin Promotes Resistance to Gefitinib in NonSmall Cell Lung Cancer Cells by Regulating Ku70 Acetylation

    Article • Molecular Therapy, March 2010, Elsevier

    Dr Saadi Khochbin, Dr Lucie Sancey

  35. 85: Identification and characterization of an original mechanism of resistance to gefitinib in non-small lung cancers: role of amphiregulin

    Article • Bulletin du Cancer, March 2010, Elsevier

    Dr Lucie Sancey

  36. 21: Drug vectorization with an integrin αvβ 3-targeted carrier for early diagnosis and cancer therapy

    Article • Bulletin du Cancer, March 2010, Elsevier

    Dr Lucie Sancey

  37. 74: Development of a novel membrane-active peptide with apoptosis-inducing activity and potent anticancer effect

    Article • Bulletin du Cancer, March 2010, Elsevier

    Dr Lucie Sancey

  38. In vivo molecular imaging of myocardial angiogenesis using the αvβ3 integrin-targeted tracer 99mTc-RAFT-RGD

    Article • Journal of Nuclear Cardiology, January 2010, Springer Science + Business Media

    Dr Lucie Sancey

  39. Application of click–click chemistry to the synthesis of new multivalent RGD conjugates

    Article • Organic & Biomolecular Chemistry, January 2010, Royal Society of Chemistry

    Dr Lucie Sancey

  40. Clustering and Internalization of Integrin αvβ3 With a Tetrameric RGD-synthetic Peptide

    Article • Molecular Therapy, May 2009, Elsevier

    Dr Lucie Sancey

  41. Targeted delivery of activatable fluorescent pro-apoptotic peptide into live cells

    Article • Organic & Biomolecular Chemistry, January 2009, Royal Society of Chemistry

    Dr Lucie Sancey

  42. Chemical and Biological Evaluations of an111In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model

    Article • Cancer Biotherapy & Radiopharmaceuticals, December 2008, Mary Ann Liebert Inc

    Dr Lucie Sancey